Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLEX: Long-term Alendronate Extension
NCT00398931Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Feb 1998
- Primary completion
- Oct 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of alendronate in osteoporosis (3 arms), sponsored by Organon & Co. Primary endpoint: Total hip bone mineral density at 5 years. Started Feb 1998; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00398931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398931.